Related references
Note: Only part of the references are listed.Upregulation of STC2 in colorectal cancer and its clinicopathological significance
Chunxiao Zhang et al.
ONCOTARGETS AND THERAPY (2019)
Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma
Yuan Wang et al.
BIOSCIENCE REPORTS (2019)
Stanniocalcin-1 and-2 effects on glucose and lipid metabolism in white adipose tissue from fed and fasted rats
Elaine Sarapio et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2019)
Effects of stanniocalcin hormones on rat brown adipose tissue metabolism under fed and fasted conditions
Elaine Sarapio et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal Transition
Chen Lin et al.
Biomed Research International (2019)
Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells
Huocong He et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Involvement of stanniocalcins in the deregulation of glycaemia in obese mice and type 2 diabetic patients
Jose Javier Lopez et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling
Jiejie Zhao et al.
FRONTIERS IN PHYSIOLOGY (2018)
Stanniocalcin 2 Regulates Non-capacitative Ca2+ Entry and Aggregation in Mouse Platelets
Esther Lopez et al.
FRONTIERS IN PHYSIOLOGY (2018)
Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer
Camilla Coulson-Gilmer et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)
STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
Shuwen Yang et al.
ONCOTARGET (2017)
Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression
Aditya D. Joshi et al.
MOLECULAR PHARMACOLOGY (2017)
Rare and low-frequency coding variants alter human adult height
Eirini Marouli et al.
NATURE (2017)
Stanniocalcin-2 overexpression reduces atherosclerosis in hypercholesterolemic mice
Lasse B. Steffensen et al.
ATHEROSCLEROSIS (2016)
The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and-2 during human ovarian follicle development
Malene R. Jepsen et al.
HUMAN REPRODUCTION (2016)
Stanniocalcin 2 improved osteoblast differentiation via phosphorylation of ERK
Juan Zhou et al.
MOLECULAR MEDICINE REPORTS (2016)
STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways
Bing Chen et al.
ONCOTARGET (2016)
Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer
Jason R. Todd et al.
ONCOTARGET (2016)
Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression
Sang-su Na et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress
Pyung-Hwan Kim et al.
BMB REPORTS (2015)
Stanniocalcin-2 Inhibits Mammalian Growth by Proteolytic Inhibition of the Insulin-like Growth Factor Axis
Malene R. Jepsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Stanniocalicin 2 Suppresses Breast Cancer Cell Migration and Invasion via the PKC/Claudin-1-Mediated Signaling
Jing Hou et al.
PLOS ONE (2015)
Aryl Hydrocarbon Receptor-Dependent Stanniocalcin 2 Induction by Cinnabarinic Acid Provides Cytoprotection against Endoplasmic Reticulum and Oxidative Stress
Aditya D. Joshi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Identification of Ran-binding protein M as a stanniocalcin 2 interacting protein and implications for androgen receptor activity
Jihye Shin et al.
BMB REPORTS (2014)
Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts
Shinichiro Miyazaki et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas
Shaojun Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Clinical significance of stanniocalcin expression in tissue and serum of gastric cancer patients
Zheng Fang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2014)
Stanniocalcin-1 and-2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways
Alice Y. S. Law et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer
Takaaki Arigami et al.
ONCOLOGY REPORTS (2013)
Identification of Stanniocalcin 2 as a Novel Aryl Hydrocarbon Receptor Target Gene
Tod A. Harper et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro
Haixiao Wang et al.
BMB REPORTS (2012)
STC2: A Predictive Marker for Lymph Node Metastasis in Esophageal Squamous-Cell Carcinoma
Yoshiaki Kita et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Stanniocalcin 2 alters PERK signalling and reduces cellular injury during cerulein induced pancreatitis in mice
Elena N. Fazio et al.
BMC CELL BIOLOGY (2011)
Stanniocalcin 2 Is a Negative Modulator of Store-Operated Calcium Entry
William Zeiger et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia
Alice Y. S. Low et al.
EXPERIMENTAL CELL RESEARCH (2010)
Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells
Alice Y. S. Law et al.
EXPERIMENTAL CELL RESEARCH (2010)
Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer
Kenji Tamura et al.
CANCER SCIENCE (2009)
cDNA cloning of Japanese flounder stanniocalcin 2 and its mRNA expression in a variety of tissues
Jihye Shin et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY (2009)
Identification of Stanniocalcin 2 as Prognostic Marker in Renal Cell Carcinoma
Hellmuth-A. Meyer et al.
EUROPEAN UROLOGY (2009)
Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma
Sonja Volland et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The murine stanniocalcin 2 gene is a negative regulator of postnatal growth
Andy C. -M. Chang et al.
ENDOCRINOLOGY (2008)
Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells
Alice Y. S. Law et al.
EXPERIMENTAL CELL RESEARCH (2008)
Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro
Sanda Raulic et al.
JOURNAL OF ENDOCRINOLOGY (2008)
The stanniocalcin family of proteins
Graham F. Wagner et al.
JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL AND INTEGRATIVE PHYSIOLOGY (2006)
Expression and regulation of stanniocalcin 1 and 2 in rat uterus during embryo implantation and decidualization
Li-Juan Xiao et al.
REPRODUCTION (2006)
Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs
AD Gagliardi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary
CW Luo et al.
ENDOCRINOLOGY (2005)
Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas
CR McCudden et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: Mediation through specific STC1 receptors
CW Luo et al.
MOLECULAR ENDOCRINOLOGY (2004)
Upregulated expression of stanniocalcin-1 during adipogenesis
M Serlachius et al.
EXPERIMENTAL CELL RESEARCH (2004)
Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties
D Ito et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor
C Zlot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of stanniocalcin 1 and 2 expression in the kidney by klotho gene
K Yahata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure
D Sheikh-Hamad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Characterization of mammalian stanniocalcin receptors - Mitochondrial targeting of ligand and receptor for regulation of cellular metabolism
CR McCudden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of stanniocalcin-1 in megakaryocytes and platelets
M Serlachius et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Possible roles for stanniocalcin during early skeletal patterning and joint formation in the mouse
SE Stasko et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Dynamic changes in stanniocalcin gene expression in the mouse uterus during early implantation
SE Stasko et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Share Paper
